Parkman Healthcare Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-903,140
Closed -$1.49M 97
2024
Q3
$1.49M Sell
903,140
-241,506
-21% -$488K 0.19% 82
2024
Q2
$2.54M Buy
1,144,646
+1,749
+0.2% +$4.11K 0.35% 70
2024
Q1
$3.06M Sell
1,142,897
-282,307
-20% -$686K 0.38% 71
2023
Q4
$4.26M Sell
1,425,204
-571,867
-29% -$742K 0.6% 54
2023
Q3
$1.96M Sell
1,997,071
-135,238
-6% -$196K 0.36% 75
2023
Q2
$2.96M Buy
2,132,309
+253,452
+13% +$354K 0.51% 59
2023
Q1
$2.99M Buy
1,878,857
+1,056,073
+128% +$5.45M 0.65% 48
2022
Q4
$5.13M Buy
822,784
+526,403
+178% +$3.76M 1.36% 25
2022
Q3
$1.99M Buy
+296,381
New +$2.04M 0.56% 56

Other funds holding ESPR